These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 31884928

  • 1. Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.
    Bagri K, Kumar A, Manisha, Kumar P.
    Mini Rev Med Chem; 2020; 20(14):1403-1435. PubMed ID: 31884928
    [Abstract] [Full Text] [Related]

  • 2. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.
    Ansari F, Ghasemi JB, Niazi A.
    Med Chem; 2020; 16(2):155-168. PubMed ID: 31092184
    [Abstract] [Full Text] [Related]

  • 3. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M, Park C, Rampogu S, Zeb A, Lee KW.
    Int J Mol Sci; 2019 Feb 25; 20(4):. PubMed ID: 30823604
    [Abstract] [Full Text] [Related]

  • 5. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 25; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 6. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P, Kar S, Roy K.
    Biosystems; 2014 Feb 25; 116():10-20. PubMed ID: 24325852
    [Abstract] [Full Text] [Related]

  • 7. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Martis EA, Chandarana RC, Shaikh MS, Ambre PK, D'Souza JS, Iyer KR, Coutinho EC, Nandan SR, Pissurlenkar RR.
    J Biomol Struct Dyn; 2015 Feb 25; 33(5):1107-25. PubMed ID: 24905476
    [Abstract] [Full Text] [Related]

  • 8. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.
    Castro A, Martinez A.
    Mini Rev Med Chem; 2001 Sep 25; 1(3):267-72. PubMed ID: 12369973
    [Abstract] [Full Text] [Related]

  • 9. Sub-pocket-focused designing of tacrine derivatives as potential acetylcholinesterase inhibitors.
    Babu A, John M, Liji MJ, Maria E, Bhaskar SJ, Binukmar BK, Sajith AM, Reddy EK, Dileep KV, Sunil K.
    Comput Biol Med; 2023 Mar 25; 155():106666. PubMed ID: 36841058
    [Abstract] [Full Text] [Related]

  • 10. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
    Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M.
    Comput Biol Chem; 2019 Jun 25; 80():463-471. PubMed ID: 31170562
    [Abstract] [Full Text] [Related]

  • 11. Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer's Disease.
    Agarwal D, Kumar S, Ambatwar R, Bhanwala N, Chandrakar L, Khatik GL.
    Cent Nerv Syst Agents Med Chem; 2024 Jun 25; 24(2):219-242. PubMed ID: 38288823
    [Abstract] [Full Text] [Related]

  • 12. QSAR analysis on tacrine-related acetylcholinesterase inhibitors.
    Wong KY, Mercader AG, Saavedra LM, Honarparvar B, Romanelli GP, Duchowicz PR.
    J Biomed Sci; 2014 Sep 20; 21(1):84. PubMed ID: 25239202
    [Abstract] [Full Text] [Related]

  • 13. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA, Ojo AB, Okolie C, Nwakama MC, Iyobhebhe M, Evbuomwan IO, Nwonuma CO, Maimako RF, Adegboyega AE, Taiwo OA, Alsharif KF, Batiha GE.
    Molecules; 2021 Apr 01; 26(7):. PubMed ID: 33915968
    [Abstract] [Full Text] [Related]

  • 14. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
    Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Edraki N, Sharifzadeh M, Khanavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar 01; 83():303-316. PubMed ID: 30396115
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 16. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
    Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.
    Chem Rec; 2021 Jan 26; 21(1):162-174. PubMed ID: 33169934
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K, El-Mernissi R, Aanouz I, Ajana MA, Lakhlifi T, Khan A, Wei DQ, Bouachrine M.
    J Mol Model; 2021 Sep 28; 27(10):302. PubMed ID: 34581863
    [Abstract] [Full Text] [Related]

  • 18. In-silico analysis and QSAR studies of tacrine hybrids with ubiquitin ligase on Alzheimer's disease.
    Pandian RS, Hemavathi K, Jayapradha R, Seenivasagam R.
    Int J Bioinform Res Appl; 2010 Sep 28; 6(6):556-70. PubMed ID: 21354962
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J.
    Eur J Med Chem; 2012 Sep 28; 55():23-31. PubMed ID: 22818849
    [Abstract] [Full Text] [Related]

  • 20. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors.
    Shiri F, Pirhadi S, Ghasemi JB.
    J Biomol Struct Dyn; 2019 Apr 28; 37(7):1800-1812. PubMed ID: 29695192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.